Inadequate Milk Production clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants
“Nicotinamide Riboside and Milk Production in the NICU”
open to eligible females ages 18 years and up
This study aims to evaluate the feasibility and effects of nicotinamide riboside (NR) supplementation in lactating mothers of infants expected to be hospitalized in the neonatal intensive care unit (NICU) for at least four weeks.
at UC Davis
Last updated: